# PIM1 and PIM3 Kinases Suppress HIV-1 Protein Expression and Particle Production Through Distinct Roles

**Authors:** Khanh Quoc Tran, Bao Quoc Le, Takaaki Koma, Naoya Doi, Tomoyuki Kondo, Nanako Komoda, Mei Udagawa, Nozomi Okumura, Chisato Gotoda, Mari Nagasaka, Takumi Ichinomiya, Yuma Inamoto, Akio Adachi, Masako Nomaguchi

PMC · DOI: 10.3390/pathogens15020167 · Pathogens · 2026-02-04

## TL;DR

PIM1 and PIM3 kinases reduce HIV-1 protein expression and virus production through different mechanisms, offering new insights into how host enzymes control viral replication.

## Contribution

The study reveals distinct and cooperative roles of PIM1 and PIM3 in suppressing HIV-1 production through transcriptional and post-transcriptional mechanisms.

## Key findings

- PIM1 and PIM3, but not PIM2, suppress HIV-1 virion production without affecting infectivity.
- PIM1 reduces HIV-1 transcription, while PIM3 diminishes viral protein expression post-transcriptionally.
- Co-expression of PIM1 and PIM3 enhances suppression of HIV-1 production and inhibits non-LTR promoters.

## Abstract

PIM kinases (PIM1, PIM2, PIM3) are serine/threonine kinases implicated in infection and reactivation of various viruses, but their roles in HIV-1 gene expression and particle production remain unclear. We examined their impact on HIV-1 and related viruses using co-transfection systems. PIM1 and PIM3, but not PIM2, markedly suppressed HIV-1 virion production without affecting infectivity. This inhibitory effect extended to transmitted/founder HIV-1 clones and SIV, indicating broad activity across lentiviruses. Kinase-dead mutants failed to reduce virion production, confirming the requirement for catalytic activity. Our data suggest that PIM1 and PIM3 act at distinct steps of HIV-1 gene expression: PIM1 reduces transcription, whereas PIM3 acts post-transcriptionally to diminish viral protein expression. Co-expression of PIM1 and PIM3 further enhanced suppression, suggesting complementary functions. Both kinases also inhibited expression from non-LTR promoters, implying involvement of general cellular factors. These findings reveal distinct and cooperative actions of PIM1 and PIM3 in limiting HIV-1 particle production, providing new insights into host kinase-mediated regulation of viral gene expression.

## Linked entities

- **Genes:** PIM1 (Pim-1 proto-oncogene, serine/threonine kinase) [NCBI Gene 5292], PIM2 (Pim-2 proto-oncogene, serine/threonine kinase) [NCBI Gene 11040], PIM3 (Pim-3 proto-oncogene, serine/threonine kinase) [NCBI Gene 415116]

## Full-text entities

- **Genes:** gag (Pr55(Gag)) [NCBI Gene 155030], REV [NCBI Gene 155908], PIM2 (Pim-2 proto-oncogene, serine/threonine kinase) [NCBI Gene 11040], CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, SAMHD1 (SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1) [NCBI Gene 25939] {aka CHBL2, DCIP, HDDC1, MOP-5, SBBI88, hSAMHD1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PIM3 (Pim-3 proto-oncogene, serine/threonine kinase) [NCBI Gene 415116] {aka pim-3}, CNTN2 (contactin 2) [NCBI Gene 6900] {aka AXT, EPEO5, FAME5, TAG-1, TAX, TAX1}, EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, PIM1 (Pim-1 proto-oncogene, serine/threonine kinase) [NCBI Gene 5292] {aka PIM}, TMED2 (transmembrane p24 trafficking protein 2) [NCBI Gene 10959] {aka P24A, RNP24, p24, p24b1, p24beta1}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}
- **Diseases:** infection (MESH:D007239), viral infection (MESH:D014777), HIV-1 infection (MESH:D015658), injury to (MESH:D014947)
- **Chemicals:** Lipofectamine 2000 (MESH:C086724), actinomycin D (MESH:D003609), cycloheximide (MESH:D003513)
- **Species:** rhinovirus A16 (no rank) [taxon 31708], Homo sapiens (human, species) [taxon 9606], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Simian immunodeficiency virus (no rank) [taxon 11723], Moloney murine leukemia virus (no rank) [taxon 11801], Human gammaherpesvirus 8 (no rank) [taxon 37296], Qubevirus faecium (species) [taxon 39804], Human T-cell leukemia virus type I (no rank) [taxon 11908], Zika virus (no rank) [taxon 64320], hepatitis C virus [taxon 11103], Enterovirus A71 (no rank) [taxon 39054], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Mutations:** K67M, K69M, serine/threonine
- **Cell lines:** MA239N — Mus musculus (Mouse), Hybridoma (CVCL_L687), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), pNL4-3 — Anopheles gambiae (African malaria mosquito), Spontaneously immortalized cell line (CVCL_Z622), TZM-bl — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_B478), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), Hep2 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_1906)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943119/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943119/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943119/full.md

---
Source: https://tomesphere.com/paper/PMC12943119